Immix Biopharma (IMMX) Shares Outstanding (Weighted Average) (2020 - 2026)
Quarterly results put Shares Outstanding (Weighted Average) at $55.4 million for Q1 2026, up 86.42% from a year ago — trailing twelve months through Mar 2026 was $55.4 million (up 86.42% YoY), and the annual figure for FY2025 was $33.0 million, up 16.55%.
Immix Biopharma has reported Shares Outstanding (Weighted Average) over the past 7 years, most recently at $55.4 million for Q1 2026.
- Shares Outstanding (Weighted Average) reached $55.4 million in Q1 2026 per IMMX's latest filing, up from $33.0 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $55.4 million in Q1 2026 and bottomed at $13.8 million in Q1 2022.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $23.4 million (2024), compared with a mean of $23.9 million.
- The largest annual shift saw Shares Outstanding (Weighted Average) soared 311.3% in 2022 before it rose 0.48% in 2023.
- Over 5 years, Shares Outstanding (Weighted Average) stood at $13.9 million in 2022, then grew by 24.87% to $17.3 million in 2023, then skyrocketed by 63.11% to $28.3 million in 2024, then grew by 16.55% to $33.0 million in 2025, then soared by 67.96% to $55.4 million in 2026.
- Business Quant data shows Shares Outstanding (Weighted Average) for IMMX at $55.4 million in Q1 2026, $33.0 million in Q4 2025, and $31.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 104.00 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 16.04 Bn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | 55.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.37 Mn |
| Dec 31, 2025 | 32.97 Mn |
| Sep 30, 2025 | 31.93 Mn |
| Jun 30, 2025 | 29.98 Mn |
| Mar 31, 2025 | 29.70 Mn |
| Dec 31, 2024 | 28.29 Mn |
| Sep 30, 2024 | 27.86 Mn |
| Jun 30, 2024 | 27.07 Mn |
| Mar 31, 2024 | 23.44 Mn |
| Dec 31, 2023 | 17.34 Mn |
| Sep 30, 2023 | 18.58 Mn |
| Jun 30, 2023 | 15.04 Mn |
| Mar 31, 2023 | 13.90 Mn |
| Dec 31, 2022 | 13.89 Mn |
| Sep 30, 2022 | 13.88 Mn |
| Jun 30, 2022 | 13.88 Mn |
| Mar 31, 2022 | 13.83 Mn |
| Dec 31, 2021 | 3.67 Mn |
| Sep 30, 2021 | 3.38 Mn |
| Jun 30, 2021 | 3.38 Mn |
| Mar 31, 2021 | 3.38 Mn |
| Dec 31, 2020 | 3.38 Mn |